Atorvastatin Calcium Hydrate/Fenofibrate

阿托伐他汀钙/非诺贝特

Report date: 2024/11/24 20:00:04

Base Information

Drug NameAtorvastatin Calcium Hydrate/Fenofibrate
Drug Alias Name非诺贝特/阿托伐他汀钙Atorvastatin Calcium Hydrate and FenofibrateAtorvastatin/fenofibratefenofibrate/AtorvastatinAtorFen +[6] 
ClassificationSmall molecules
Mechanisms of ActionPeroxisome proliferator activated receptor agonistsHMG-CoA reductase inhibitors
TargetsPeroxisome proliferator activated receptorHMG-CoA reductase
Therapy Area/IndicationsDyslipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMexico
CombinationsYes FenofibrateAtorvastatin Calcium Hydrate
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVeloxis Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLaboratorios Silanes Sa De Cv
Active IndicationsN/A
Inactive IndicationsDyslipidemias

Other Information

ATC CodeN/A
Related LinksN/A